CD8A and neoplasm: These analyses revealed that 1200V-treated tumor cells stimulated stronger OVA-specific CD8+ T cell responses (0.78%) than 600V-treated ones (0.16%) (Figure 1C), indicating that in vitro 1200V-treated apoptotic tumor cells are indeed more immunogenic.